1. Home
  2. CDNA vs IRMD Comparison

CDNA vs IRMD Comparison

Compare CDNA & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$27.77

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo iRadimed Corporation

IRMD

iRadimed Corporation

HOLD

Current Price

$94.44

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDNA
IRMD
Founded
1998
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
2007
2014

Fundamental Metrics

Financial Performance
Metric
CDNA
IRMD
Price
$27.77
$94.44
Analyst Decision
Buy
Strong Buy
Analyst Count
6
1
Target Price
$28.00
$116.00
AVG Volume (30 Days)
866.7K
120.6K
Earning Date
04-28-2026
05-01-2026
Dividend Yield
N/A
0.95%
EPS Growth
N/A
16.67
EPS
0.05
0.45
Revenue
$48,324,000.00
$83,814,000.00
Revenue This Year
$16.01
$12.38
Revenue Next Year
$11.31
$11.31
P/E Ratio
$557.00
$208.60
Revenue Growth
18.93
14.43
52 Week Low
$10.96
$55.11
52 Week High
$28.42
$107.90

Technical Indicators

Market Signals
Indicator
CDNA
IRMD
Relative Strength Index (RSI) 71.83 55.09
Support Level $14.59 $90.62
Resistance Level N/A $97.63
Average True Range (ATR) 1.39 3.32
MACD 0.39 -0.05
Stochastic Oscillator 92.28 48.71

Price Performance

Historical Comparison
CDNA
IRMD

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About IRMD iRadimed Corporation

iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.

Share on Social Networks: